Clinical Trial Update: CsA+EPAG/HPAG+Romiplostim N01 in the Treatment of Newly-diagnosed SAA/TD-NSAA [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes a regimen of cyclosporine with EPAG/HPAG and romiplostim for newly diagnosed severe aplastic anemia or transfusion-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Eltrombopag (eltrombopag)
• Romiplostim (romiplostim)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Severe Aplastic Anemia (SAA), Transfusion-dependent Non-severe Aplastic Anemia | Phase 2 | Status: NOT_YET_RECRUITING